Nick Maskell leads the Bristol Academic Respiratory Unit. He also runs a tertiary pleural disease service and chairs the regional mesothelioma multi-disciplinary team.
He was the Chief Investigator for AERATOR, one of the only non-therapeutic urgent public health badged COVID-19 studies in the UK.
One of his major research interests is the evaluation of novel biomarkers for investigating and managing pleural disease.
